EWCZ or ELF: Which Is the Better Value Stock Right Now?

European Wax Center (EWCZ) is identified as the superior value investment compared to e.l.f. Beauty (ELF), according to Zacks' analysis. EWCZ holds a Zacks Rank of #1 (Strong Buy) and an 'A' Value grade, supported by stronger earnings estimate revisions and significantly more attractive valuation metrics. Key differentials include EWCZ's forward P/E of 9.15, PEG of 0.50, and P/B of 3.15, contrasting sharply with ELF's P/E of 34.60, PEG of 2.23, and P/B of 9.39, positioning EWCZ as a more compelling opportunity for value-oriented investors.

Analysis

Based on a comparative valuation analysis within the cosmetics sector, European Wax Center (EWCZ) presents a more compelling case for value-oriented investors than e.l.f. Beauty (ELF). This conclusion is supported by the Zacks Rank system, which assigns EWCZ a #1 (Strong Buy) rating, indicating a trend of positive earnings estimate revisions and an improving analyst outlook. In contrast, ELF holds a #3 (Hold) rating. The valuation disparity is stark across key metrics: EWCZ trades at a forward P/E of 9.15, significantly below ELF's 34.60. Furthermore, EWCZ's PEG ratio of 0.50 suggests its stock price is undervalued relative to its expected earnings growth, whereas ELF's PEG of 2.23 indicates a premium valuation. This is further corroborated by the price-to-book (P/B) ratios, with EWCZ at 3.15 and ELF at a much higher 9.39. These quantitative factors culminate in EWCZ receiving a top-tier 'A' grade for Value in the Zacks Style Scores system, while ELF receives an 'F', solidifying EWCZ's position as the statistically superior value stock in this direct comparison.

Key Decisions for Investors

• Value-focused investors should consider European Wax Center (EWCZ) as a potentially undervalued opportunity, given its 'Strong Buy' rating and significant valuation discount to e.l.f. Beauty (ELF) on P/E, PEG, and P/B metrics.
• Investors holding e.l.f. Beauty (ELF) for its value characteristics should reassess their position, as its 'F' value grade and premium multiples suggest limited upside from a valuation standpoint.
• Monitor upcoming earnings estimate revisions for both companies, as the positive trend for EWCZ is a critical component of its current buy thesis and any deceleration could warrant a re-evaluation.
• For portfolios with exposure to the consumer discretionary space, rotating capital from an expensive name like ELF to a comparatively cheaper one like EWCZ could be a prudent strategy to enhance value alignment.